LMAT stock forecast
Our latest prediction for LeMaitre Vascular, Inc.'s stock price was made on the Jan. 13, 2020 when the stock price was at 38.46$.
In the short term (2weeks), LMAT's stock price should underperform the market by -3.60%. During that period the price should oscillate between -5.31% and +3.69%.
In the medium term (3months), LMAT's stock price should underperform the market by -4.29%. During that period the price should oscillate between -15.75% and +12.57%.Get email alerts
Create a solid portfolio with LMAT
About LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
At the moment the company generates 115M USD in revenues.
On its last earning announcement, the company reported a profit of 0.95$ per share.
The book value per share is 6.20$
Three months stock forecastJan. 13, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|